What is Staar Surgical's stock-based comp?

Staar Surgical (STAA) reported stock-based comp of $4.82M in Q1 2026.

How has Staar Surgical's stock-based comp changed year-over-year?

Staar Surgical's stock-based comp decreased by 19.8% year-over-year, from $6.02M to $4.82M.

What is the long-term trend for Staar Surgical's stock-based comp?

Over 4 years (2021 to 2025), Staar Surgical's stock-based comp has grown at a 20.3% compound annual growth rate (CAGR), from $14.61M to $30.59M.

What does stock-based comp mean?

Total non-cash stock-based compensation expense for equity awards (RSUs, options, ESPP), added back to net income in cash flow reconciliation.

Staar Surgical STAA Stock-Based Comp

Stock-Based Comp at other companies

Johnson & JohnsonJNJ

$300M+4.2%

Bausch Health CompaniesBHC

$52M+20.9%

IAR

Integra LifeSciencesIART

$5.17M+176%

ITG

Integer HoldingsITGR

$6.66M-3.2%

GlaukosGKOS

$19.14M+47.4%

HRO

HarrowHROW

$3.84M-15.8%

Other financials

Income statement

See full

Revenue$93.5M+120%

Gross profit$68.9M+146%

Operating income$8.0M+114%

Net income$5.2M+110%

EPS (diluted)$0.10+109%

Balance sheet

See full

Cash & equivalents$131.9M-23.8%

Total debt$37.3M+1.7%

Total equity$352.4M+0.7%

Total assets$451.1M-1.4%

Cash flow

See full

Operating cash flow-$21.7M-278%

CapEx$443.0K-69.8%

Free cash flow-$22.1M-207%

Valuation

See full

Market cap$1.44B+77.9%

Enterprise value$1.35B+100.0%

P/S5×+2.1×

Profitability

See full

Gross margin76.9%+2.9pp

Operating margin-9.1%-3.5pp

Net margin-7.2%-3.0pp

FCF margin-19.6%+55.9pp

Returns & leverage

See full

Return on equity-6%-2.4pp

Debt / equity0.1×0.0×

Current ratio5.1×+0.3×

Where this comes from

Reported directly by Staar Surgical in its filing.

Tagged under the XBRL concept us-gaap:ShareBasedCompensation.

The official record: Staar Surgical’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Staar Surgical's stock-based comp.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Staar Surgical's stock-based comp?: Staar Surgical (STAA) reported stock-based comp of $4.82M in Q1 2026.
How has Staar Surgical's stock-based comp changed year-over-year?: Staar Surgical's stock-based comp decreased by 19.8% year-over-year, from $6.02M to $4.82M.
What is the long-term trend for Staar Surgical's stock-based comp?: Over 4 years (2021 to 2025), Staar Surgical's stock-based comp has grown at a 20.3% compound annual growth rate (CAGR), from $14.61M to $30.59M.
What does stock-based comp mean?: Total non-cash stock-based compensation expense for equity awards (RSUs, options, ESPP), added back to net income in cash flow reconciliation.